Skip to main content

Search form

Open Close
Open menu Home
  • About us
    • Mission & Vision
    • Strategy
    • Governance
    • Project team
  • Our research
    • Our scientific approach
    • Posters
    • Publications
    • Project Brochure
  • Patient Engagement
    • RADAR-AD in a nutshell
    • Patient and Public Involvment
    • Patient Advisory Board
  • Partners
  • Newsroom
  • Contact
RADAR-CNS RADAR-base MyProjectPlaza
HomePartners

Partners

https://altoida.com/
Alternate text
https://www.alzheimer-europe.org/
https://www.cbg-meb.nl/
https://www.certh.gr/root.en.aspx
https://www.fraunhofer.de/en.html
https://www.janssen.com/neuroscience
https://ki.se/en/startpage
https://www.kcl.ac.uk/
https://www.lilly.com/
Https://www.lygature.org
https://www.novartis.com/
https://www.softwareag.com/nl/
Alternate text
https://www.takeda.com/
http://www.ox.ac.uk/
Alternate text
https://www.vumc.nl/research.htm
The Hyve
https://thehyve.nl/

Co-leads on this project are Janssen Pharmaceutica and King’s College London

Funding statement

RADAR-AD receives funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 806999. This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA. See www.imi.europa.eu for more details.

Subscribe to our newsletter

And stay up to date about the latest news and developments.

Newsletter archive

  • Terms and conditions
  • Privacy Policy
  • Cookies Policy
  • Disclaimer
Close

RADAR-AD Newsletter